CytomX(CTMX) - 2025 Q4 - Earnings Call Presentation

Varsetatug Masetecan: Phase 1 Dose Expansion Interim Data Update March 16, 2026 © 2026 CytomX Therapeutics, Inc. 1 Legal Disclaimer This presentation (including any oral commentary that accompanies this presentation) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this presentation, including statements rega ...